Bortezomib-induced peripheral neurotoxicity in human multiple myeloma-bearing mice.
C Meregalli(University of Milano-Bicocca), P Marmiroli(University of Milano-Bicocca), A Canta(University of Milano-Bicocca), E Ballarini(University of Milano-Bicocca), Valentina Carozzi(University of Milano-Bicocca), Gabriella Nicolini(University of Milano-Bicocca), Monia Orciani(Marche Polytechnic University), Guido Cavaletti(Bellvitge University Hospital), N Oggioni(University of Milano-Bicocca), C Ceresa(University of Milano-Bicocca), Barbara Sala(University of Milano-Bicocca), A Chiorazzi(University of Milano-Bicocca), V Rodriguez-Menendez(University of Milano-Bicocca), Luca Crippa(University of Milano-Bicocca)
PubMed
June 25, 2015
Cited by 15
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
|Annals of Oncology|2020|319
Erythropoietin both protects from and reverses experimental diabetic neuropathy
|Proceedings of the National Academy of Sciences|2004|252
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
|Proceedings of the National Academy of Sciences|2013|175